Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Provog M 500mg/0.2mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Samson Laboratories Pvt Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Provog M 500mg/0.2mg Tablet SR

Diabetam 500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetam 500mg/0.2mg Extended-Release Tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar or feeling well. Discontinuation without medical consultation risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Potential side effects include nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rash. These are usually transient and self-limiting. Persistent or concerning side effects warrant medical attention. Your physician can offer management strategies for any bothersome side effects. This medication is contraindicated in type 1 diabetes mellitus, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women must consult their doctor before use. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to assess blood cell counts and liver function.

Primary Ingredients of Provog M 500mg/0.2mg Tablet SR

No information provided. Please provide the text you wish to be rephrased.

Uses of Provog M 500mg/0.2mg Tablet SR

Managing type 2 diabetes

Major Benefits of Provog M 500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Provog M 500mg/0.2mg Sustained-Release tablets should be taken with a meal.

Common Side effects of Provog M 500mg/0.2mg Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Provog M 500mg/0.2mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or dividing it. Provog M 500mg/0.2mg Sustained-Release tablets should be administered with a meal.

How Provog M 500mg/0.2mg Tablet SR works:

The extended-release tablet, Provog M 500mg/0.2mg, contains a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Provog M 500mg/0.2mg SR tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Provog M 500mg/0.2mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Medical advice is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Provog M 500mg/0.2mg tablets are likely not suitable for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Provog M 500mg/0.2mg SR Tablets. Nevertheless, patients using this medication concurrently with other diabetes treatments like sulfonylureas, insulin, or repaglinide should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Patients with kidney impairment should use Provog M 500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. Provog M 500mg/0.2mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Provog M 500mg/0.2mg sustained-release tablets to individuals with hepatic impairment. Seek medical advice.

What if you forget to take Provog M 500mg/0.2mg Tablet SR :

Should you forget to take your Provog M 500mg/0.2mg sustained-release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Provog M 500mg/0.2mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Provog M 500mg/0.2mg Tabl...
69
MRP 80
13% off